Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors

Gastroenterology

Volumn 135, Issue 4, 2008, Pages 1185-1191

  Challine, Dominique ^a,b   Chevaliez, Stéphane ^a,b   Pawlotsky, Jean Michel ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANTIBODY ISOLATION; ANTIGEN DETECTION; ARTICLE; CELL TRANSPLANTATION; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; TISSUE TRANSPLANTATION; VIRUS TRANSMISSION;

EID: 53049106558     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.07.011     Document Type: Article

References (25)

1. Alter M.J. Epidemiology and prevention of hepatitis B. Semin Liver Dis 23 (2003) 39-46
2. Eastlund T. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 4 (1995) 455-477
3. Locasciulli A., Alberti A., Bandini G., et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 86 (1995) 3236-3240
4. Hoft R.H., Pflugfelder S.C., Forster R.K., et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 16 (1997) 132-137
5. Natov S.N., and Pereira B.J. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (part 1: hepatitis B virus). Transpl Infect Dis 4 (2002) 117-123
6. Francisci D., Aversa F., Coricelli V., et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica 91 (2006) 980-982
7. Wachs M.E., Amend W.J., Ascher N.L., et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 59 (1995) 230-234
8. Roche B., Samuel D., Gigou M., et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 26 (1997) 517-526
9. Dickson R.C., Everhart J.E., Lake J.R., et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 113 (1997) 1668-1674
10. De Feo T.M., Poli F., Mozzi F., et al. Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: a collaborative study. Transplant Proc 37 (2005) 1238-1239
11. Chazouilleres O., Mamish D., Kim M., et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 343 (1994) 142-146
12. Challine D., Roudot-Thoraval F., Sabatier P., et al. Serological viral testing of cadaveric cornea donors. Transplantation 82 (2006) 788-793
13. Zou S., Dodd R.Y., Stramer S.L., et al. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 351 (2004) 751-759
14. Lefrere J.J., Sellami F., Larderie P., et al. Six years' experience testing organ donors for viral markers in France. Transfusion 37 (1997) 565-566
15. Tugwell B.D., Patel P.R., Williams I.T., et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 143 (2005) 648-654
16. Challine D., Pellegrin B., Bouvier-Alias M., et al. HIV and hepatitis C virus RNA in seronegative organ and tissue donors. Lancet 364 (2004) 1611-1612
17. Stuyver L., De Gendt S., Van Geyt C., et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81 (2000) 67-74
18. Tiollais P., Pourcel C., and Dejean A. The hepatitis B virus. Nature 317 (1985) 489-495
19. Vyas G.N., Rao K.R., and Ibrahim A.B. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 178 (1972) 1300-1301
20. Carman W.F., Van Deursen F.J., Mimms L.T., et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26 (1997) 1658-1666
21. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32 (2005) 102-112
22. Tordjeman M., Fontan G., Rabillon V., et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 41 (1993) 221-229
23. Chang T.T., Gish R.G., de Man R., et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 354 (2006) 1001-1010
24. Lai C.L., Shouval D., Lok A.S., et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354 (2006) 1011-1020
25. Chen C.J., Yang H.I., Su J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73